Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity

Glioblastoma multiforme (GBM), the most common and lethal tumor of the adult brain, generally shows chemo- and radioresistance. MicroRNAs (miRs) regulate physiological processes, such as resistance of GBM cells to temozolomide (TMZ). Although miRs are attractive targets for cancer therapeutics, the...

Full description

Bibliographic Details
Main Authors: Jessian L Munoz, Sarah A Bliss, Steven J Greco, Shakti H Ramkissoon, Keith L Ligon, Pranela Rameshwar
Format: Article
Language:English
Published: Elsevier 2013-01-01
Series:Molecular Therapy: Nucleic Acids
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253116301895
_version_ 1819180425925361664
author Jessian L Munoz
Sarah A Bliss
Steven J Greco
Shakti H Ramkissoon
Keith L Ligon
Pranela Rameshwar
author_facet Jessian L Munoz
Sarah A Bliss
Steven J Greco
Shakti H Ramkissoon
Keith L Ligon
Pranela Rameshwar
author_sort Jessian L Munoz
collection DOAJ
description Glioblastoma multiforme (GBM), the most common and lethal tumor of the adult brain, generally shows chemo- and radioresistance. MicroRNAs (miRs) regulate physiological processes, such as resistance of GBM cells to temozolomide (TMZ). Although miRs are attractive targets for cancer therapeutics, the effectiveness of this approach requires targeted delivery. Mesenchymal stem cells (MSCs) can migrate to the sites of cancers, including GBM. We report on an increase in miR-9 in TMZ-resistant GBM cells. miR-9 was involved in the expression of the drug efflux transporter, P-glycoprotein. To block miR-9, methods were developed with Cy5-tagged anti-miR-9. Dye-transfer studies indicated intracellular communication between GBM cells and MSCs. This occurred by gap junctional intercellular communication and the release of microvesicles. In both cases, anti-miR-9 was transferred from MSCs to GBM cells. However, the major form of transfer occurred with the microvesicles. The delivery of anti-miR-9 to the resistant GBM cells reversed the expression of the multidrug transporter and sensitized the GBM cells to TMZ, as shown by increased cell death and caspase activity. The data showed a potential role for MSCs in the functional delivery of synthetic anti-miR-9 to reverse the chemoresistance of GBM cells.
first_indexed 2024-12-22T22:14:09Z
format Article
id doaj.art-8d46d48f55664da682c5f1a56d409c80
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-22T22:14:09Z
publishDate 2013-01-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-8d46d48f55664da682c5f1a56d409c802022-12-21T18:10:48ZengElsevierMolecular Therapy: Nucleic Acids2162-25312013-01-012C10.1038/mtna.2013.60Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred ChemosensitivityJessian L Munoz0Sarah A Bliss1Steven J Greco2Shakti H Ramkissoon3Keith L Ligon4Pranela Rameshwar5Rutgers University–Graduate School of Biomedical Science, Newark, New Jersey, USARutgers University–Graduate School of Biomedical Science, Newark, New Jersey, USANew Jersey Medical School, Newark, New Jersey, USADepartment of Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Boston, Massachusetts, USADepartment of Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Boston, Massachusetts, USANew Jersey Medical School, Newark, New Jersey, USAGlioblastoma multiforme (GBM), the most common and lethal tumor of the adult brain, generally shows chemo- and radioresistance. MicroRNAs (miRs) regulate physiological processes, such as resistance of GBM cells to temozolomide (TMZ). Although miRs are attractive targets for cancer therapeutics, the effectiveness of this approach requires targeted delivery. Mesenchymal stem cells (MSCs) can migrate to the sites of cancers, including GBM. We report on an increase in miR-9 in TMZ-resistant GBM cells. miR-9 was involved in the expression of the drug efflux transporter, P-glycoprotein. To block miR-9, methods were developed with Cy5-tagged anti-miR-9. Dye-transfer studies indicated intracellular communication between GBM cells and MSCs. This occurred by gap junctional intercellular communication and the release of microvesicles. In both cases, anti-miR-9 was transferred from MSCs to GBM cells. However, the major form of transfer occurred with the microvesicles. The delivery of anti-miR-9 to the resistant GBM cells reversed the expression of the multidrug transporter and sensitized the GBM cells to TMZ, as shown by increased cell death and caspase activity. The data showed a potential role for MSCs in the functional delivery of synthetic anti-miR-9 to reverse the chemoresistance of GBM cells.http://www.sciencedirect.com/science/article/pii/S2162253116301895
spellingShingle Jessian L Munoz
Sarah A Bliss
Steven J Greco
Shakti H Ramkissoon
Keith L Ligon
Pranela Rameshwar
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
Molecular Therapy: Nucleic Acids
title Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
title_full Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
title_fullStr Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
title_full_unstemmed Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
title_short Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
title_sort delivery of functional anti mir 9 by mesenchymal stem cell derived exosomes to glioblastoma multiforme cells conferred chemosensitivity
url http://www.sciencedirect.com/science/article/pii/S2162253116301895
work_keys_str_mv AT jessianlmunoz deliveryoffunctionalantimir9bymesenchymalstemcellderivedexosomestoglioblastomamultiformecellsconferredchemosensitivity
AT sarahabliss deliveryoffunctionalantimir9bymesenchymalstemcellderivedexosomestoglioblastomamultiformecellsconferredchemosensitivity
AT stevenjgreco deliveryoffunctionalantimir9bymesenchymalstemcellderivedexosomestoglioblastomamultiformecellsconferredchemosensitivity
AT shaktihramkissoon deliveryoffunctionalantimir9bymesenchymalstemcellderivedexosomestoglioblastomamultiformecellsconferredchemosensitivity
AT keithlligon deliveryoffunctionalantimir9bymesenchymalstemcellderivedexosomestoglioblastomamultiformecellsconferredchemosensitivity
AT pranelarameshwar deliveryoffunctionalantimir9bymesenchymalstemcellderivedexosomestoglioblastomamultiformecellsconferredchemosensitivity